Findings
small-intestinal injury
SECONDARY
In this secondary analysis of a randomized clinical trial with 394 participants, aspirin, clopidogrel, or their combination were associated with progressive gastric and small-intestinal injury in a substantial proportion of patients after percutaneous coronary intervention, particularly during dual antiplatelet therapy compared with monotherapy.